Intellia Therapeutics Inc (NTLA)
SG&A Expenses
$152.05M
TTM · Period ending: · USD
NTLA SG&A Expenses
Latest reported$152.05Mperiod ending
Latest reported$152.05Mperiod ending
NTLA TTM SG&A Expenses ($8.28M → $152.05M)
TTM SG&A Expenses
High-resolution chart · PNG
NTLA sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 152,052,000 | |
| 157,936,000 | |
| 152,100,000 | |
| 151,469,000 | |
| 149,866,000 | |
| 137,951,000 | |
| 140,035,000 | |
| 136,585,000 | |
| 121,281,000 | |
| 120,140,000 | |
| 116,497,000 | |
| 111,129,000 | |
| 103,871,000 | |
| 95,351,000 | |
| 90,306,000 | |
| 88,788,000 | |
| 85,354,000 | |
| 79,905,000 | |
| 71,096,000 | |
| 59,751,000 | |
| 51,606,000 | |
| 46,449,000 | |
| 44,169,000 | |
| 42,382,000 | |
| 40,247,000 | |
| 41,839,000 | |
| 41,058,000 | |
| 40,790,000 | |
| 40,629,000 | |
| 35,316,000 | |
| 32,189,000 | |
| 33,694,000 | |
| 31,135,000 | |
| 29,699,000 | |
| 28,025,000 | |
| 22,930,000 | |
| 21,924,000 | |
| 19,284,000 | |
| 16,798,000 | |
| 14,489,000 | |
| 11,315,000 | |
| 10,419,000 | |
| 8,283,000 | |
| 8,188,500 | |
| 6,824,500 |